Therapeutic and palliative benefit from single-agent irinotecan in multiply treated and highly refractory cases of lymphoma Meeting Abstract


Authors: Caces, D. D.; Halaas, J.; Hamlin, P.; Noy, A.; Kewalramani, T.; Portlock, C. S.; Zelenetz, A. D.; O'Connor, O. A.; Gerecitano, J. F.
Abstract Title: Therapeutic and palliative benefit from single-agent irinotecan in multiply treated and highly refractory cases of lymphoma
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Language: English
ACCESSION: WOS:000276606606003
PROVIDER: wos
Notes: Meeting Abstract: e19554 -- Source: Wos
MSK Authors
  1. Carol Portlock
    178 Portlock
  2. Ariela Noy
    204 Noy
  3. Andrew D Zelenetz
    546 Zelenetz
  4. Paul Hamlin
    170 Hamlin